The Form 4 filing was filed on November 18, 2026. It covers sales from November 16 through November 17, 2026. Form 4 is an SEC report of changes in company shares owned by insiders, including company officers.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 78,375 |
| Price | $215.63 |
| Total Transaction Value | $16,900,019.37 |
| Insider | |
| Ticker Symbol | MRNA |
| Company | Moderna, Inc. |
| Insider Name | Hoge Stephen |
| Insider Title | President |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 1,311,095 |
| Position Size Change | 5.64% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of Moderna (MRNA) shares by Stephen Hoge, the company's president. The transaction code is S, which means a sale. The reported activity includes four transactions.
What was the average price of the transaction?
The average sale price was $215.63 per share for the sales dated November 16–17. Separate prices and share counts for each of the four transactions are not available.
How did this transaction affect the insider's holdings?
Stephen Hoge sold 78,375 shares and reported owning 1,311,095 shares afterward. The shares sold made up 5.64% of the shares he owned before the sales.
What's the total transaction value?
The total reported value was $16,900,019.37 across the four sales.
Are there any special circumstances around this transaction?
The transaction details note a Rule 10b5-1 trading plan. These plans set trading instructions in advance. No footnote text is available to show whether the reference covers all four sales or only some. The plan's start date and trading schedule are also unknown. A plan reference alone does not show whether the trades met the rule's legal requirements.
Source: SEC Form 4.
For research purposes only; not investment advice.